Cognitive Behavioral Therapy vs Zopiclone for Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial | Sleep Medicine | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia.  Sleep. 2000;23:243-30810737342Google Scholar
Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia.  J Psychiatr Res. 1997;31:333-3469306291Google ScholarCrossref
Ohayon MM. Epidemiology of insomnia.  Sleep Med Rev. 2002;6:97-11112531146Google ScholarCrossref
Pallesen S, Nordhus IH, Nielsen GH.  et al.  Prevalence of insomnia in the adult Norwegian population.  Sleep. 2001;24:771-77911683480Google Scholar
Roth T, Roehrs T. Insomnia: epidemiology, characteristics, and consequences.  Clin Cornerstone. 2003;5:5-1514626537Google ScholarCrossref
Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia.  Sleep. 1999;22:(suppl 2)  S379-S38510394611Google Scholar
Avidan AY. Insomnia in the geriatric patient.  Clin Cornerstone. 2003;5:51-6014626541Google ScholarCrossref
Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders.  JAMA. 1989;262:1479-14842769898Google ScholarCrossref
Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care.  Am J Psychiatry. 1997;154:1417-14239326825Google Scholar
Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995.  Sleep. 1999;22:(suppl 2)  S386-S39310394612Google Scholar
Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates.  Arch Gen Psychiatry. 1985;42:225-2322858188Google ScholarCrossref
Riedel BW, Lichstein KL. Strategies for evaluating adherence to sleep restriction treatment for insomnia.  Behav Res Ther. 2001;39:201-21211153973Google ScholarCrossref
Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States.  Sleep. 1999;22:(suppl 2)  S354-S35810394607Google Scholar
Morin CM, Wooten V. Psychological and pharmacological approaches to treating insomnia.  Clin Psychol Rev. 1996;16:521-542. doi:10.1016/0272-7358(96)00027-xGoogle ScholarCrossref
Hohagen F, Kappler C, Schramm E.  et al.  Prevalence of insomnia in elderly general practice attenders and the current treatment modalities.  Acta Psychiatr Scand. 1994;90:102-1087976454Google ScholarCrossref
Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF III, Kupfer DJ. Benzodiazepines and zolpidem for chronic insomnia.  JAMA. 1997;278:2170-21779417012Google ScholarCrossref
Holbrook A, Crowther R, Lotter A, Endeshaw Y. The role of benzodiazepines in the treatment of insomnia.  J Am Geriatr Soc. 2001;49:824-82611454123Google ScholarCrossref
Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits.  BMJ. 2005;331:116916284208Google ScholarCrossref
National Institutes of Health.  National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.  Sleep. 2005;28:1049-105716268373Google Scholar
 Concern Over Ambien and Driving. “CBS News.” CBS television. March 8, 2006
Stuever H. Snooze alarm: the pill that drove us to sleep. Washington Post. May 6, 2006: C01
Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age.  Health Psychol. 2006;25:3-1416448292Google ScholarCrossref
Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia.  Am J Psychiatry. 1994;151:1172-11808037252Google Scholar
Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis.  J Consult Clin Psychol. 1995;63:79-897896994Google ScholarCrossref
Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia.  Arch Intern Med. 2004;164:1888-189615451764Google ScholarCrossref
Montgomery P, Dennis J. Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev . 2003;(1):CD003161. Review12535460
Edinger JD, Means MK. Cognitive-behavioral therapy for primary insomnia.  Clin Psychol Rev. 2005;25:539-55815951083Google ScholarCrossref
Montgomery P, Dennis J. A systematic review of non-pharmacological therapies for sleep problems in later life.  Sleep Med Rev. 2004;8:47-6215062210Google ScholarCrossref
Pallesen S, Nordhus IH, Kvale G. Nonpharmacological interventions for insomnia in older adults: a meta-analysis of treatment efficacy.  Psychotherapy. 1998;35:472-482Google ScholarCrossref
Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.  JAMA. 1999;281:991-99910086433Google ScholarCrossref
Moldofsky H. Sleep and pain.  Sleep Med Rev. 2001;5:385-39612531004Google ScholarCrossref
Edinger JD, Fins A. The distribution and clinical significance of sleep time misperceptions among insomniacs.  Sleep. 1995;18:232-2397618020Google Scholar
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician.  J Psychiatr Res. 1975;12:189-1981202204Google ScholarCrossref
First MB, Spitzer RL, Gibbon M, Williams JBW. Structural Clinical Interview for DSM-IV Axis I Disorders. New York, NY: Biometrics Research Department; 1995
Rechtschaffen A, Kales A. A Manual of Standardised Terminology and Scoring System for Sleep Stages of Human Sleep. Los Angeles: University of California at Los Angeles, Brain Information Service/Brain Research Institute; 1968
Lorenzo JL, Barbanoj MJ. Variability of sleep parameters across multiple laboratory sessions in healthy young subjects: the “very first night effect.”  Psychophysiology. 2002;39:409-41312212632Google ScholarCrossref
Lichstein KL, Riedel BW. Behavioral assessment and treatment of insomnia: a review with an emphasis on clinical application.  Behav Ther. 1994;25:659-688Google ScholarCrossref
Morin CM. Insomnia: Psychological Assessment and Management. New York, NY: Guilford Press; 1993
Morgan K, Thompson J, Dixon S, Tomeny M, Mathers N. Predicting longer-term outcomes following psychological treatment for hypnotic-dependent chronic insomnia.  J Psychosom Res. 2003;54:21-2912505552Google ScholarCrossref
Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed.  Sleep. 1987;10:45-563563247Google Scholar
Bootzin RR, Nicassio PM. Behavioral treatments for insomnia. In: Hersen M, Eissler R, Miller P, eds Progress of Behavior Modification Vol 6.. New York, NY: Academic Press; 1978:1-45
Beck AT. Cognitive Therapy and the Emotional Disorders. New York, NY: International University Press; 1976
Jacobsen E. You Can Sleep Well. New York, NY: McGraw-Hill Book Co; 1938
Hajak G. A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience.  Drug Saf. 1999;21:457-46910612270Google ScholarCrossref
Noble S, Langtry HD, Lamb HM. Zopiclone: an update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia.  Drugs. 1998;55:277-3029506247Google ScholarCrossref
Norwegian Institute of Public Health.  Drug Consumption in NorwayOslo: Norwegian Institute of Public Health; 2004
Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Laurence Erlbaum; 1988
Smith MT, Perlis ML, Park A.  et al.  Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia.  Am J Psychiatry. 2002;159:5-1111772681Google ScholarCrossref
Bastien CH, Morin CM, Ouellet MC, Blais FC, Bouchard S. Cognitive-behavioral therapy for insomnia: comparison of individual therapy, group therapy, and telephone consultations.  J Consult Clin Psychol. 2004;72:653-65915301650Google ScholarCrossref
Strom L, Pettersson R, Andersson G. Internet-based treatment for insomnia: a controlled evaluation.  J Consult Clin Psychol. 2004;72:113-12014756620Google ScholarCrossref
Morin CM, Beaulieu-Bonneau S, LeBlanc M. Self-help treatment for insomnia: a randomized controlled trial.  Sleep. 2005;28:1319-132716295218Google Scholar
Original Contribution
June 28, 2006

Cognitive Behavioral Therapy vs Zopiclone for Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial

Author Affiliations

Author Affiliations: Department of Clinical Psychology (Drs Sivertsen, Omvik, Havik, Kvale, Nielsen, and Nordhus); Department of Psychosocial Science (Dr Pallesen); Norwegian Competence Center for Sleep Disorders (Drs Bjorvatn, Pallesen, and Nordhus); and Department of Public Health and Primary Health Care (Dr Bjorvatn), University of Bergen, Bergen, Norway.

JAMA. 2006;295(24):2851-2858. doi:10.1001/jama.295.24.2851

Context Insomnia is a common condition in older adults and is associated with a number of adverse medical, social, and psychological consequences. Previous research has suggested beneficial outcomes of both psychological and pharmacological treatments, but blinded placebo-controlled trials comparing the effects of these treatments are lacking.

Objective To examine short- and long-term clinical efficacy of cognitive behavioral therapy (CBT) and pharmacological treatment in older adults experiencing chronic primary insomnia.

Design, Setting, and Participants A randomized, double-blinded, placebo-controlled trial of 46 adults (mean age, 60.8 y; 22 women) with chronic primary insomnia conducted between January 2004 and December 2005 in a single Norwegian university-based outpatient clinic for adults and elderly patients.

Intervention CBT (sleep hygiene, sleep restriction, stimulus control, cognitive therapy, and relaxation; n = 18), sleep medication (7.5-mg zopiclone each night; n = 16), or placebo medication (n = 12). All treatment duration was 6 weeks, and the 2 active treatments were followed up at 6 months.

Main Outcome Measures Ambulant clinical polysomnographic data and sleep diaries were used to determine total wake time, total sleep time, sleep efficiency, and slow-wave sleep (only assessed using polysomnography) on all 3 assessment points.

Results CBT resulted in improved short- and long-term outcomes compared with zopiclone on 3 out of 4 outcome measures. For most outcomes, zopiclone did not differ from placebo. Participants receiving CBT improved their sleep efficiency from 81.4% at pretreatment to 90.1% at 6-month follow-up compared with a decrease from 82.3% to 81.9% in the zopiclone group. Participants in the CBT group spent much more time in slow-wave sleep (stages 3 and 4) compared with those in other groups, and spent less time awake during the night. Total sleep time was similar in all 3 groups; at 6 months, patients receiving CBT had better sleep efficiency using polysomnography than those taking zopiclone.

Conclusion These results suggest that interventions based on CBT are superior to zopiclone treatment both in short- and long-term management of insomnia in older adults.

Trial Registration Identifier: NCT00295386